Answer
Danaparoid sodium is not recommended during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia because severe postoperative bleeding may occur, unless no other antithrombotic treatment is available.
Sources for this answer
- Danaparoid Sodium 750 anti-Xa units/0.6 ml, solution for injectionViatris (formerly Mylan or Upjohn) · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked